6-Thio-2'-Deoxyguanosine

Drug identity checked against registry records

Also recorded as 6-thio-dG; THIO; ateganosine

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLCNCT06908304Maia BiotechnologyPhase 3Recruiting2027-07-31Estimated
THIO Sequenced With Cemiplimab in Advanced NSCLCNCT05208944Maia BiotechnologyPhase 2Active not recruiting2027-09-30Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.